Health Care & Life Sciences » Biotechnology | Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd.
Stock Exchange Korea Exchange
EPS
 KRW557.49
Market Cap
 KRW340.08 B
Shares Outstanding
 20.8 M
Public Float
 15.73 M

Profile

Address
17th Floor, Shinan Building
Seoul SL 06179
Korea, Republic Of
Employees -
Website http://www.kangstem.com
Updated 09/14/2018
KangStem Biotech Co., Ltd. develops and commercializes stem cell therapies. Its therapies include next generation and gene-loaded stem cell. In addition, it also provides contract research and manufacturing services and drug screening services.

Financials

View All
Created with Highcharts 5.0.14Kang Stem Biotech Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.2 8362 8363 7143 7145 7545 7548 3008 30010 22510 2252013201420152016201702.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Kang Stem Biotech Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.4114112082081 4851 4858438439 1339 1332013201420152016201702.5k5k7.5k10k

Kyung-Sun Kang
Chairman
Tae-Hwa Lee
Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.